Dissection of single-cell landscapes for the development of chimeric antigen receptor T cells in Hodgkin lymphoma
Open Access
- 3 April 2025
- journal article
- Published by American Society of Hematology in Blood
- Vol. 145 (14) , 1536-1552
Abstract
The success of targeted therapies for hematological malignancies has heralded their potential as both salvage treatment and early treatment lines, reducing the need for high-dose, intensive, and often toxic chemotherapeutic regimens. For young patients with classic Hodgkin lymphoma (cHL), immunotherapies provide the possibility to lessen long-term, treatment-related toxicities. However, suitable therapeutic targets are lacking. By integrating single-cell dissection of the tumor landscape and an in-depth, single-cell–based off-tumor antigen prediction, we identify CD86 as a promising therapeutic target in cHL. CD86 is highly expressed on Hodgkin and Reed-Sternberg cancer cells and cHL-specific tumor-associated macrophages. We reveal CD86–CTLA-4 as a key suppressive pathway in cHL, driving T-cell exhaustion. Cellular therapies targeting CD86 had extraordinary efficacy in vitro and in vivo and were safe in immunocompetent mouse models without compromising bacterial host defense in sepsis models. Our results prove the potential value of anti-CD86 immunotherapies for treating cHL.Keywords
This publication has 66 references indexed in Scilit:
- A Mass Spectrometric-Derived Cell Surface Protein AtlasPLOS ONE, 2015
- A New Cecal Slurry Preparation Protocol with Improved Long-Term Reproducibility for Animal Models of SepsisPLOS ONE, 2014
- Molecular mechanisms of T cell co-stimulation and co-inhibitionNature Reviews Immunology, 2013
- Hodgkin lymphomaJournal of Clinical Investigation, 2012
- Macrophages predict treatment outcome in Hodgkin's lymphomaHaematologica, 2011
- State-of-the-art Issues in Hodgkin’s Lymphoma SurvivorshipCurrent Oncology Reports, 2010
- Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2Molecular Therapy, 2010
- CTLA-4 Control over Foxp3 + Regulatory T Cell FunctionScience, 2008
- Origin and pathogenesis of nodular lymphocyte–predominant Hodgkin lymphoma as revealed by global gene expression analysisJournal of Experimental Medicine, 2008
- Hodgkin and non-Hodgkin lymphoma involving bone marrowSeminars in Diagnostic Pathology, 2003